Company Overview: e.l.f. Beauty is a cosmetic company offering a range of products including makeup, lip products, and beauty tools.
Analysts' Outlook: The company has received a Zacks Rank #5 (Strong Sell) due to a bearish earnings outlook and is part of a poorly ranked cosmetics industry.
Stock Performance: e.l.f. shares have dropped approximately 36% in 2025, significantly underperforming the S&P 500, with recent quarterly results failing to boost investor confidence.
Investment Recommendations: For investors seeking better opportunities, it is suggested to focus on stocks with a Zacks Rank #1 (Strong Buy) or #2 (Buy) for a stronger earnings outlook.
ELF
$78.37+Infinity%1D
Analyst Views on ELF
Wall Street analysts forecast ELF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELF is 124.33 USD with a low forecast of 100.00 USD and a high forecast of 155.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
Wall Street analysts forecast ELF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELF is 124.33 USD with a low forecast of 100.00 USD and a high forecast of 155.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Buy
4 Hold
0 Sell
Strong Buy
Current: 78.600
Low
100.00
Averages
124.33
High
155.00
Current: 78.600
Low
100.00
Averages
124.33
High
155.00
TD Cowen
Oliver Chen
Buy
downgrade
$110 -> $100
2025-11-12
Reason
TD Cowen
Oliver Chen
Price Target
$110 -> $100
2025-11-12
downgrade
Buy
Reason
TD Cowen analyst Oliver Chen lowered the firm's price target on Elf Beauty to $100 from $110 and keeps a Buy rating on the shares. The firm views the recent pullback following Q2 results as a buying opportunity as its valuation appears compelling.
Baird
Outperform
downgrade
$145 -> $125
2025-11-06
Reason
Baird
Price Target
$145 -> $125
2025-11-06
downgrade
Outperform
Reason
Baird lowered the firm's price target on Elf Beauty to $125 from $145 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results where 20226 guidance was introduced but below expectations.
Goldman Sachs
Buy
downgrade
$155 -> $135
2025-11-06
Reason
Goldman Sachs
Price Target
$155 -> $135
2025-11-06
downgrade
Buy
Reason
Goldman Sachs lowered the firm's price target on Elf Beauty to $135 from $155 and keeps a Buy rating on the shares. Elf's Q2 results were mixed, with revenue missing expectations due to a temporary pause in shipments but EPS exceeding estimates on stronger margins and lower SG&A, the analyst tells investors in a research note. Management's FY26 outlook disappointed, calling for only 3%-4% organic growth amid tough comparisons and shipment timing issues, despite strong underlying consumption trends. While the stock may face near-term pressure, the company's conservative guidance and continued market share gains suggest potential upside once shipments normalize, the firm says.
Canaccord
Susan Anderson
Buy
downgrade
$165 -> $136
2025-11-06
Reason
Canaccord
Susan Anderson
Price Target
$165 -> $136
2025-11-06
downgrade
Buy
Reason
Canaccord analyst Susan Anderson lowered the firm's price target on Elf Beauty to $136 from $165 and keeps a Buy rating on the shares. The firm said they reported Q2 results led by Rhode which continues to shine but the rest of the business is seeing near-term normalization.
About ELF
e.l.f. Beauty, Inc. is a multi-brand beauty company. The Company offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skincare products. The Company's family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People, Keys Soulcare, and rhode. Its e.l.f. SKIN is an ingredient-focused, dermatologist-developed formulas for every eye, lip and face. The Company operates across beauty categories including eye, lip, and face makeup, beauty tools and accessories, and skincare products. Its color cosmetics and skin care products are broadly sold through food, drug, and mass channels, as well as through department stores and direct and specialty channels. The Company sells its products with retailers in the United States, as well as internationally. It also sells its products online through its own direct e-commerce channels, as well as through other e-commerce Websites.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
